Advocacy Alert

Urge Your Lawmakers to Support Essential Health System Designation

CDC Reports Rise in Invasive Meningococcal Disease

Faridat Animashaun
April 15, 2024

The Centers for Disease Control and Prevention (CDC) issued a health advisory about an increase in invasive serogroup Y meningococcal disease in the United States and provided recommendations for health care providers and the public.

In 2023, the CDC saw the highest number of reported meningococcal disease cases in the United States since 2014. The advisory states that a specific meningococcal strain, sequence type (ST) 1466, is responsible for most invasive serogroup Y cases, and this strain is disproportionately affecting individuals ages 30 to 60, Black or African American individuals, and individuals with HIV.

The CDC recommends that health care providers:

  • Maintain a heighted awareness of potential invasive meningococcal disease.
  • Start immediate antibiotic treatment for suspected meningococcal disease.
  • Be aware that patients with invasive meningococcal disease may not present with symptoms of meningitis and may present with bloodstream infection or septic arthritis.
  • Ensure that meningococcal vaccinations are up to date for all people the CDC recommends receive the vaccine.

Additionally, health care providers should immediately notify their state or local health department in the case of suspected or confirmed cases of meningococcal disease. Health care providers can email meningnet@cdc.gov with questions or concerns.

Contact Senior Vice President of Policy and Advocacy Beth Feldpush, DrPH, at bfeldpush@essentialhospitals.org or 202.585.0111 with questions.

Keep up with the pulse of America's Essential Hospitals

Members: Sign up for email updates.